NVEC · NVE Corporation Common Stock
View on chartInsiders & Stakes
| BAKER DANIEL A President and CEO | ▼ Sell | Open Market | 17,932 Shares held | 9/8/2026 | View profile |
| HOLLISTER PATRICIA M Director | ▼ Sell | Other | 1,040 Shares held | 12/5/2024 | View profile |
| GLARNER TERRENCE Director | ▼ Sell | Open Market | 700 Shares held | 11/5/2024 | View profile |
| BRACKE JAMES W Director | ▲ Buy | Open Market | 600 Shares held | 4/4/2025 | View profile |
| KRAMP RICHARD W Director | ▲ Buy | Option Exercise | 575 Shares held | 5/9/2023 | View profile |
| Wei Xuan Kelly Director | ▼ Sell | Other | 0 Shares held | 8/12/2026 | View profile |
Transaction History
| BAKER DANIEL A | ▼ Sell | Open Market | 2,000 | $202K | 9/8/2026 |
| BAKER DANIEL A | ▼ Sell | Open Market | 19,140 | $1.9M | 9/8/2026 |
| BAKER DANIEL A | ▼ Sell | Open Market | 2,000 | $218K | 8/27/2026 |
| BAKER DANIEL A | ▼ Sell | Open Market | 2,000 | $220K | 8/27/2026 |
| BAKER DANIEL A | ▼ Sell | Open Market | 1,731 | $185K | 8/25/2026 |
| BAKER DANIEL A | ▼ Sell | Open Market | 1,500 | $182K | 8/17/2026 |
| Wei Xuan Kelly | ▼ Sell | Other | 538 | $66K | 8/12/2026 |
| BAKER DANIEL A | ▼ Sell | Open Market | 15,222 | $1.7M | 7/29/2026 |
| BAKER DANIEL A | ▼ Sell | Open Market | 3,260 | $383K | 7/28/2026 |
| BAKER DANIEL A | ▲ Buy | Option Exercise | 1,344 | $158K | 7/27/2026 |
| BAKER DANIEL A | ▲ Buy | Option Exercise | 853 | $100K | 7/27/2026 |
| BAKER DANIEL A | ▲ Buy | Option Exercise | 1,496 | $176K | 7/27/2026 |
| BAKER DANIEL A | ▲ Buy | Option Exercise | 864 | $102K | 7/27/2026 |
| BAKER DANIEL A | ▲ Buy | Option Exercise | 757 | $89K | 7/27/2026 |
| BAKER DANIEL A | ▲ Buy | Option Exercise | 1,061 | $125K | 7/27/2026 |
| BAKER DANIEL A | ▼ Sell | Open Market | 1,518 | $178K | 7/27/2026 |
| Wei Xuan Kelly | ▲ Buy | Option Exercise | 538 | $63K | 7/27/2026 |
| BAKER DANIEL A | ▼ Sell | Open Market | 103 | $7K | 1/29/2026 |
| BAKER DANIEL A | ▼ Sell | Open Market | 1,155 | $86K | 1/27/2026 |
| BRACKE JAMES W | ▲ Buy | Open Market | 100 | $6K | 4/4/2025 |
| HOLLISTER PATRICIA M | ▲ Buy | Option Exercise | 1,000 | $57K | 12/5/2024 |
| HOLLISTER PATRICIA M | ▼ Sell | Other | 2,000 | $150K | 12/5/2024 |
| HOLLISTER PATRICIA M | ▲ Buy | Option Exercise | 1,000 | $57K | 12/5/2024 |
| GLARNER TERRENCE | ▼ Sell | Open Market | 500 | $37K | 11/5/2024 |
| GLARNER TERRENCE | ▼ Sell | Open Market | 344 | $27K | 8/15/2024 |
| GLARNER TERRENCE | ▲ Buy | Option Exercise | 344 | $27K | 8/13/2024 |
| GLARNER TERRENCE | ▼ Sell | Open Market | 200 | $15K | 6/11/2024 |
| GLARNER TERRENCE | ▼ Sell | Open Market | 275 | $22K | 1/25/2024 |
| GLARNER TERRENCE | ▲ Buy | Option Exercise | 275 | $22K | 1/22/2024 |
| HOLLISTER PATRICIA M | ▲ Buy | Option Exercise | 1,000 | $50K | 5/15/2023 |
| HOLLISTER PATRICIA M | ▲ Buy | Option Exercise | 1,000 | $68K | 5/15/2023 |
| HOLLISTER PATRICIA M | ▼ Sell | Open Market | 2,000 | $172K | 5/15/2023 |
| BAKER DANIEL A | ▼ Sell | Open Market | 20,000 | $1.7M | 5/10/2023 |
| KRAMP RICHARD W | ▲ Buy | Option Exercise | 225 | $20K | 5/9/2023 |
| KRAMP RICHARD W | ▲ Buy | Option Exercise | 350 | $31K | 5/9/2023 |
| GLARNER TERRENCE | ▲ Buy | Option Exercise | 1,000 | $57K | 3/3/2023 |
| GLARNER TERRENCE | ▼ Sell | Open Market | 1,000 | $78K | 3/3/2023 |
| BRACKE JAMES W | ▲ Buy | Open Market | 100 | $5K | 5/9/2022 |
| BRACKE JAMES W | ▲ Buy | Open Market | 100 | $6K | 2/4/2022 |
| BRACKE JAMES W | ▲ Buy | Open Market | 300 | $18K | 1/25/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
NVEC reports new medical sensor innovation
A recent Seeking Alpha article highlights NVE Corporation’s introduction of a new medical sensor technology. The development expands the company’s product line and may enhance its long‑term growth prospects. The news is relevant as it could influence future revenue streams and market positioning.
NVEC reports new medical sensor innovation. A recent Seeking Alpha article highlights NVE Corporation’s introduction of a new medical sensor technology. The development expands the company’s product line and may enhance its long‑term growth prospects. The news is relevant as it could influence future revenue streams and market positioning.